Effects of dehydroepiandrosterone (DHEA) supplementation on hormonal, metabolic and behavioral status in patients with hypoadrenalism

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Journal of Endocrinological Investigation

• Publication date

  2004-09-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/BF03347515PMID 15636426
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Dehydroepiandrosterone supplementation in women with adrenal failure: impact on twenty‐four hour GH secretion and IGF‐related parameters

  2004cited by this paper
• Dehydroepiandrosterone modulates endothelial nitric oxide synthesis via direct genomic and nongenomic mechanisms.

  2003cited by this paper
• Replacement of dehydroepiandrosterone in adrenal failure: no benefit for subjective health status and sexuality in a 9-month, randomized, parallel group clinical trial.

  2003cited by this paper
• Dehydroepiandrosterone supplementation and bone turnover in middle-aged to elderly men.

  2002cited by this paper
• Low dose dehydroepiandrosterone affects behavior in hypopituitary androgen-deficient women: a placebo-controlled trial.

  2002cited by this paper
• Dehydroepiandrosterone replacement therapy

  2001cited by this paper
• Dehydroepiandrosterone replacement in women with adrenal insufficiency: effects on body composition, serum leptin, bone turnover, and exercise capacity.

  2001cited by this paper
• Dehydroepiandrosterone replacement therapy.

  2001cited by this paper
• Double‐blind placebo‐controlled trial of oral dehydroepiandrosterone in patients with advanced HIV disease

  2001cited by this paper
• Oral dehydroepiandrosterone (DHEA) replacement therapy in women with Addison's disease

  2000cited by this paper
• Improvement in mood and fatigue after dehydroepiandrosterone replacement in Addison's disease in a randomized, double blind trial.

  2000cited by this paper
• Dehydroepiandrosterone replacement in women with adrenal insufficiency.

  1999cited by this paper
• Treatment of systemic lupus erythematosus with dehydroepiandrosterone: 50 patients treated up to 12 months.

  1998cited by this paper
• The effect of six months treatment with a 100 mg daily dose of dehydroepiandrosterone (DHEA) on circulating sex steroids, body composition and muscle strength in age‐advanced men and women

  1998cited by this paper
• Gonadal and Adrenal Androgens Are Potent Regulators of Human Bone Cell Metabolism In Vitro

  1997cited by this paper
• Dehydroepiandrosterone (DHEA) and DHEA-S interact with 1,25-dihydroxyvitamin D3 (1,25(OH)2D3) to stimulate human osteoblastic cell differentiation.

  1997cited by this paper
• Panhypopituitarism as a model to study the metabolism of dehydroepiandrosterone (DHEA) in humans.

  1997cited by this paper
• Dehydroepiandrosterone (DHEA): a fountain of youth?

  1996cited by this paper
• Replacement of DHEA in Aging Men and Women

  1995cited by this paper
• Effects of replacement dose of dehydroepiandrosterone in men and women of advancing age.

  1994cited by this paper
• 90291970 The effects of oral dehydroepiandrosterone on endocrine-metabolic parameters in postmenopausal women

  1991cited by this paper
• The effects of oral dehydroepiandrosterone on endocrine-metabolic parameters in postmenopausal women.

  1990cited by this paper
• Dehydroepiandrosterone reduces serum low density lipoprotein levels and body fat but does not alter insulin sensitivity in normal men.

  1988cited by this paper
• The psychosocial adjustment to illness scale (PAIS).

  1986cited by this paper
• Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man

  1985cited by this paper
• The Mini-Mental State Examination.

  1983cited by this paper
• SCL-90: an outpatient psychiatric rating scale--preliminary report.

  1973cited by this paper
• Journal of Clinical Endocrinology and Metabolism Printed in U.S.A. Copyright © 1997 by The Endocrine Society Physiological Changes in Dehydroepiandrosterone Are Not Reflected by Serum Levels of Active Androgens and Estrogens But of Their Metabolites: Intr

  year unknowncited by this paper
• The Journal of Clinical Endocrinology & Metabolism Printed in U.S.A. Copyright © 2000 by The Endocrine Society Quantitative Insulin Sensitivity Check Index: A Simple, Accurate Method for Assessing Insulin Sensitivity In Humans

  year unknowncited by this paper

• Low serum dehydroepiandrosterone levels are associated with diabetic retinopathy in patients with type 2 diabetes mellitus

  2023cites this paper
• Iukfglkpgu hqt fkcipquku cpf vtgcvogpv qh cftgpcl kpuuhÞekgpe{ in adults

  2022cites this paper
• The role for long-term use of dehydroepiandrosterone in adrenal insufficiency

  2022cites this paper
• Central intracrine DHEA synthesis in ageing-related neuroinflammation and neurodegeneration: therapeutic potential?

  2018cites this paper
• Digital Delivery of Meditative Movement Training Improved Health of Cigarette-Smoke-Exposed Subjects

  2018cites this paper
• The effects of dehydroepiandrosterone on sexual function: a systematic review

  2017cites this paper
• Doping Status of DHEA Treatment for Female Athletes with Adrenal Insufficiency

  2017cites this paper
• Understanding clinical outcome in patients with pituitary disease : a biopsychosocial approach

  2017cites this paper
• Is DHEA replacement beneficial in chronic adrenal failure?

  2015cites this paper
• Androgenmangel bei Frauen: Wann klinisch relevant?

  2014cites this paper
• Psychological morbidity and impaired quality of life in patients with stable treatment for primary adrenal insufficiency: cross-sectional study and review of the literature.

  2014cites this paper
• Guidelines for diagnosis and treatment of adrenal insufficiency in adults

  2014cites this paper
• Impaired health‐related quality of life in Addison's disease – impact of replacement therapy, comorbidities and socio‐economic factors

  2014cites this paper
• Dehydroepiandrosterone supplementation in elderly men: a meta-analysis study of placebo-controlled trials.

  2013cites this paper
• What Affects the Quality of Life in Autoimmune Addison’s Disease?

  2013cites this paper
• Therapy of adrenal insufficiency: an update

  2013cites this paper
• Androgen replacement therapy in women

  2012cites this paper
• Dehydroepiandrosterone (DHEA)--a precursor steroid or an active hormone in human physiology.

  2011cites this paper
• CHAPTER 20 – Sexual Dysfunction in Men and Women

  2011cites this paper
• Regulation of cortisol secretion in humans: relation to vasopressin action at the adrenals in macronodular and micronodular adrenocortical tumours; and well-being in Addison’s Disease.

  2011cites this paper
• DHEA, important source of sex steroids in men and even more in women.

  2010cites this paper
• Management of steroid replacement in adrenal insufficiency.

  2010cites this paper
• Dehydroepiandrosterone to enhance physical performance: myth and reality.

  2010cites this paper
• State and Public School Life and Health Insurance Board Clinical and Fiscal Drug Utilization and Evaluation Committee

  2010cites this paper
• Blood lipids may have influence on the emotional well-being in young men

  2010cites this paper
• Therapeutic management of adrenal insufficiency.

  2009cites this paper
• A systematic review and meta-analysis of randomized placebo-controlled trials of DHEA treatment effects on quality of life in women with adrenal insufficiency.

  2009cites this paper
• Effect of intravaginal dehydroepiandrosterone (Prasterone) on libido and sexual dysfunction in postmenopausal women

  2009cites this paper
• Substitution mit Nebennierensteroiden

  2008cites this paper
• For information on reprint requests of more than 101 and commercial reprints contact

  2008cites this paper
• Effect of dehydroepiandrosterone supplementation on bone mineral density, bone markers, and body composition in older adults: the DAWN trial

  2008cites this paper
• Dehydroepiandrosterone Administration in Treating Medical and Neuropsychiatric Disorders

  2008cites this paper
• In vitro and in vivo analysis of the effects of dehydroepiandrosterone on metabolic and vascular risk

  2008cites this paper
• One-year therapy with 10mg/day DHEA alone or in combination with HRT in postmenopausal women: effects on hormonal milieu.

  2008cites this paper
• Long-term DHEA replacement in primary adrenal insufficiency: a randomized, controlled trial.

  2008cites this paper
• [Replacement therapy with adrenal steroids].

  2008cites this paper
• Androgen Actions and the Ovary

  2008cites this paper
• Therapies for adrenal insufficiency

  2007cites this paper
• Impaired subjective health status in 256 patients with adrenal insufficiency on standard therapy based on cross-sectional analysis.

  2007cites this paper
• DHEA: why, when, and how much--DHEA replacement in adrenal insufficiency.

  2007cites this paper
• New evidence for protective effects of DHEAS on health among men but not women

  2006cites this paper
• Addison's disease.

  2006cites this paper
• The native anti-glucocorticoid paradigm.

  2006cites this paper
• Androgen therapy in women: an Endocrine Society Clinical Practice guideline.

  2006cites this paper
• CLINICAL PRACTICE GUIDELINE Androgen Therapy in Women: An Endocrine Society Clinical Practice Guideline

  2006cites this paper
• Hypopituitarism : A Randomized , Double-Blind , Placebo-Controlled Study Effects of Testosterone Replacement in Androgen-Deficient Women with Society

  2006cites this paper
• Anabolic Steroids: A Survey Of 500 Users

  2005cites this paper
• Osteopenia in pediatric patients : when and and how to intervene ?

  2005cites this paper
• Direct agonist/antagonist functions of dehydroepiandrosterone.

  2005cites this paper
• Dehydroepiandrosterone replacement therapy

  2001cites this paper
• ENDOCRINOLOGÍA Y NUTRICIÓN

  year unknowncites this paper
• CRN BACKGROUNDER 2 DHEA : The Basic Facts DHEA is not an anabolic steroid

  year unknowncites this paper